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Generating high accuracy peptide binding data in high 
throughput with yeast surface display and SORTCERY
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Abstract
Library methods are widely used to study protein-protein interactions, and high-throughput 
screening or selection followed by sequencing can identify a large number of peptide ligands for a 
protein target. In this chapter we describe a procedure called "SORTCERY" that can rank the 
affinities of library members for a target with high accuracy. SORTCERY follows a three-step 
protocol. First, fluorescence activated cell sorting (FACS) is used to sort a library of yeast 
displayed peptide ligands according to their affinities for a target. Second, all sorted pools are deep 
sequenced. Third, the resulting data are analyzed to create a ranking. We demonstrate an 
application of SORTCERY to the problem of ranking peptide ligands for the anti-apoptotic 
regulator Bcl-xL.
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1. Introduction
High-throughput analysis of functional mutations in proteins, peptides or DNA by deep 
sequencing is emerging as a powerful technique. Properties such as protein stability, 
enzymatic activity and peptide ligand or DNA binding have been studied [1–16]. The 
general approach involves screening a library of mutants or performing a selection for a 
desired function. Library sequences in pre- and post-selected pools are then identified by 
next-generation sequencing, and computational routines are used to extract information 
about how sequence relates to function.
Many selection or screening processes have been employed for these types of studies, 
including in vitro assays, phage display, yeast-surface display in combination with 
fluorescence activated cell sorting (FACS), and in vivo assays. Some studies have used the 
observed frequencies of mutant variants in selected pools to infer sequence-function 
relationships [1–5]. As an alternative measure, enrichment scores have been calculated from 
the ratio of pre- and post-selection frequencies [6–14]. The effects of mutations in particular 
sequence positions have been investigated, either by experimentally screening single-mutant 
libraries or by assuming positional independence during computational post-processing. 
Position weight matrices have been built that score binding, stability, and function from 
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sequence using this approach, sometimes with correction for non-specific binding or 
consideration of enrichment changes over multiple selection rounds [5,12,13]. Analyzing 
single-residue substitutions benefits from enhanced statistical power, because it is easy to 
saturate a single-position sequence space. But important context dependent effects may be 
neglected in this type of analysis.
In this chapter we introduce a high-accuracy alternative to enrichment-based methods for 
probing mutational effects on the affinity of peptide ligands. Our protocol “SORTCERY” 
comprises the three steps of selection, deep sequencing and computational analysis (Figure 1 
A). The selection process involves two-color cell sorting of a yeast-surface displayed library 
based on the expression levels of displayed peptides and levels of binding to a target (Figure 
1 B). Our sorting protocol builds on reports that two-color FACS can accurately distinguish 
between binders of different affinities [15–19] and agrees with a theoretical model 
describing the expected signals for clones expressing peptides with a range of binding 
strengths [20]. This model can guide sorting of a library into pools according to binding 
affinity, and the pools can then be deep-sequenced to obtain information about individual 
library member affinities. SORTCERY extracts information from deep-sequenced library 
pools using computational routines that rank observed mutant sequences according to 
binding strength.
Applying SORTCERY to study helical peptide affinities for the apoptosis-regulating protein 
Bcl-xL, we obtained extremely accurate rankings for ~1000 sequences over a range of 
dissociation constants from 0.1 nM to 60 nM (Figure 2 A). Our study is described in 
reference [20] and the reader is referred to that paper for in-depth exposition of the theory 
underlying SORTCERY, the results when applied to Bcl-xL, and further discussion of 
strengths and limitations of this method. A special variant of our approach is described here 
(Figure 2 B, Note 9), that can potentially be used to analyze much larger libraries.
2. Materials
2.1. Cell Culture Media
1. SD+CAA/SG+CAA: Dissolve 5 g casamino acids, 1.7 g yeast nitrogen base, 
5.3 g ammonium sulfate, 10.2 g Na2HPO4-7H2O and 8.6 g NaH2PO4-H2O in 
700 ml water and autoclave for 15 min at 22 psi and 120 °C. For growth media 
(SD + CAA), dissolve 50 g glucose in 50 ml water then sterilize with a 0.2 µm 
filter. Add 40 ml of this 50% glucose solution to the autoclaved media and fill 
up to 1 l with sterile water. For induction media (SG + CAA), dissolve 20 g 
galactose in 100 ml water then sterilize with a 0.2 µm filter. Add 100 ml of this 
20% galactose solution to the autoclaved media and fill up to 1 l with sterile 
water.
2.2 Fluorescence activated cell sorting
1. Low protein binding 0.45 µm filter plates or bottle-top filters
9Because gate setting requires a significant amount of time gates should be drawn prior to sample preparation. Adjust PMT voltages 
so that the library's FACS profile largely covers the pre-set gates. Adjustments may be guided by a set of standards.
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2. BSS pH 8.0: 50 mM Tris, 100 mM NaCl, 1 mg/ml BSA
3. Primary antibody mixture: anti-HA (Roche) 1:100 dilution and anti-Myc 
(Sigma) 1:100 dilution in BSS
4. Secondary antibody mixture: APC-labeled anti-mouse (BD Biosciences) 1:40 
dilution and PE-labeled anti-rabbit (Sigma) 1:100 dilution in BSS
2.3 Deep Sequencing Sample Preparation (see Note 1)
1. Zymoprep Yeast Plasmid Miniprep I (Zymo Research)
2. Isopropanole
3. High-Fidelity DNA Polymerase (e.g. Phusion)
4. Thermocycler
5. Gel equipment
6. PCR purification and gel extraction kits (QiaGen)
7. MmeI (New England Biolabs): MmeI restriction enzyme, NEB Cut Smart 
Buffer, 1 mM SAM
8. T4 Ligase
9. Primers and oligos
3. Methods
3.1 Cell growth and induction of yeast-surface display library (see Note 2)
1. Dilute cells to OD600 of 0.05 in SD + CAA and grow for 8 h at 30 °C.
2. Dilute cells to OD600 of 0.005 in SD + CAA and grow to OD of 0.1 – 0.4 at 
30 °C.
3. Dilute cells to OD600 of 0.025 in SG + CAA and grow to OD of 0.2 – 0.5 at 
30 °C for induction of peptide expression.
3.2 Gate setting
1. SORTCERY uses a two-color FACS setup to monitor expression (Fe) and 
binding (Fb) signals on a log/log or biexponential scale. On a log(Fb) vs. 
log(Fe) plot, points of equal binding strength lie on a line with a slope of 1 
[20]. Subdivide the log/log plot accordingly into areas (gates) of different 
1We fine-tuned the protocols described in section 3.4 using material from the specified suppliers. We have not tested corresponding 
products from other suppliers and it is possible that these will work too for deep sequencing sample preparation. Experimenters may 
need to adjust protocols according to the specific products they use.
2This growth protocol has been optimized for EBY100 cells that have been transformed with a pCTCON2 plasmid [17]. The 
experimenter may have to choose other parameters for a different setup. In the authors' experience, cell densities may have an impact 
on the quality of FACS profiles. Low quality FACS profiles can lead to sub-optimal sorts with respect to affinity. Users of the 
procedure should strictly monitor cell densities. The first growth step in this protocol ensures that samples contain mostly live and 
healthy cells for correct measurements of ODs. It may be possible to skip this step if cells are not grown up from frozen stocks or 
plates.
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affinities by dissecting it with lines of slopes of 1 (red lines in Figure 3). The 
number, position and spacing of the lines will affect the performance of the 
procedure. We recommend an equal spacing between lines as this will result in 
optimal resolution between binders of different affinities. The number of lines 
(and the resulting gates) depends on the required resolution. This can be 
determined by measuring the FACS profiles of several yeast-displayed 
standards (see Note 3). Lines should be positioned such that the gates cover an 
area from the strongest binders to the baseline signal of binding. FACS profiles 
of standards can help determine whether the experimental setup will generate 
samples with quality appropriate for a SORTCERY sort (see Note 4).
2. Gate boundaries should be set to exclude cells without significant expression 
signal and to prevent cells in the binding baseline from being captured in gates 
for higher affinities. Cutoffs can be established by monitoring the FACS profile 
of a non-binding yeast clone and noting: (1) the position of non-expressing 
cells (blob in the lower left corner of Figure 3), and (2) the binding baseline 
(lower right area in Figure 3). Determine appropriate cutoffs and set gate 
lower-edge boundaries accordingly (see example: green edges in Figure 3).
3. Cell sorters assign maximum signal values to any signal intensity above their 
scale of measurement. Such signals have, therefore, not been accurately 
determined. Exclude the maximum expression and binding signal areas from 
the gates by setting gate boundaries accordingly (see example: blue edges in 
Figure 3).
3.3 Cell sorting
1. Filter grown and induced yeast cells (step 3.1) and wash twice with BSS.
2. Incubate cells with target molecule in BSS for 2 h at 21 °C (see Notes 5 & 6). 
Shake gently during incubation.
3The number and position of gates can be chosen based on a set of standards. Record the FACS profiles of several yeast-displayed 
standards in a same-day experiment at a target concentration chosen based on anticipated affinities. Construct a set of gates to be 
tested for adequate resolution. Determine for each FACS profile how many cells would have hit each gate. This provides a distribution 
over the gates for each standard. Then, simulate an experiment by drawing random samples with a size of ten cells for each standard. 
(Note that clones should be sampled more often than this during an actual SORTCERY sort. However, real samples may experience 
additional experimental noise during preparation for deep sequencing. Thus, we find 10 cells in this procedure provides useful 
information.) Use the random sample to calculate for each standard X and gate i, calculate the normalized frequency, fiX, with which 
the standard would be observed in the gate. Calculate the probability that standard X is a better binder than standard Y based on the 
random samples, using the formula given in section 3.5 point 5. Compare the result to the actual affinities of the standards. Repeat this 
many times to determine the range of values the probability can take. Sufficient resolution, i.e. a sufficient number and appropriate 
placement of gates, will be indicated by mostly high probabilities for the correct ordering of standards.
4Record several FACS profiles for standards. Consider data for expressing cells that have binding signals mostly above the baseline. 
Use a cutoff line with a slope of −1 to separate expressing from non-expressing cells; Using other cutoffs may bias the analysis. Adjust 
the retained data by subtracting the average binding and expression signals from each data point. Calculate the covariance matrix of 
the data. Determine the first principal component by calculating the matrix's eigenvectors and eigenvalues. The vector with the largest 
corresponding eigenvalue indicates the orientation of the first principle component. Determine the first principle component's slope, 
i.e. the slope of the vector. High quality FACS profiles should result in a value close to 1 (Figure 4). Reduction in quality can have 
many different experimental origins, such as inappropriate growth protocols (see Notes 1 and 2), excess dissociation of target molecule 
during washing steps (see Note 8) or non-specific binding to tube walls (see Note 5).
5BSA is used as a blocking agent to prevent non-specific binding to the cells and, more importantly, the test tube walls. Adsorption to 
the tube walls may lead to significant depletion of target molecules and distortion of FACS profiles.
6The number of target molecules should be in excess of the number of surface-displayed peptides. E.g. our yeast strain expresses 
about 30,000 peptides per cell [24]. If 106 cells are incubated in 700 µl of 1 nM target molecule solution, then at most ~10% of the 
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3. Filter cells and wash twice with BSS.
4. Incubate with mixture of primary antibodies (20 µl per 106 cells, see Notes 7 & 
8) at 4 °C.
5. Filter cells and wash twice with BSS.
6. Incubate with mixture of secondary antibodies at 4 °C.
7. Filter cells and wash twice with BSS. Resuspend cells in BSS for sorting.
8. Sort cells into each individual gate and retain sorted pools for deep sequencing 
analysis (see Notes 9 & 10). Note the number of cells sorted into each pool. 
Also record the library distribution across all gates by recording how many 
cells hit each gate during a set time interval, e.g. a minute. This information is 
important for the deep sequencing analysis (section 3.5, point 4).
3.4 Deep sequencing sample preparation
3.4.1 DNA extraction—
1. If >80,000 cells are sorted, spin cells down, aspirate supernatant and add 150 
µl of solution 1 from the Zymoprep kit + 2 µl Zymolase. For smaller numbers 
of cells, directly add 50 µl of solution 1 per 100 µl cell suspension + 2 µl 
Zymolase per 150 µl total volume.
2. Incubate at 37 °C for 1 h on a shaker.
3. Successively add 150 µl of solutions 2 and 3 per 150 µl incubation volume and 
vortex after each addition, spin down precipitate and retain supernatant.
4. Add 1 volume isopropanol and 0.1 volume 3 M NaOAc to each volume of 
DNA extract. Store at −20 °C over night.
5. Spin at 13000 rpm at 4 °C for 10 min. Carefully remove supernatant. 
Resuspend DNA pellet in 20 µl sterile water (pellet may not be visible for 
small numbers of sorted cells).
target molecules are bound. Adjust your incubation volume accordingly. Choose the concentration of target molecule appropriately to 
investigate a specific range of affinities (see Note 3).
7We have used an HA tag for detection of expression and a Myc tag for detection of binding. However, other tags may work with our 
protocol and may be preferred by the experimenter. Required antibody concentrations may depend on the exact choice. Always test 
whether the antibodies provide high quality FACS profiles (see Note 3).
8Swift application of antibodies is crucial because washing steps can disturb the equilibrium between free and bound target molecules. 
We have found that fully prepared samples are relatively stable, possibly because the antibodies crosslink the bound target molecules 
and thereby dramatically decrease dissociation.
10If the number of chosen gates exceeds the number of sample tubes that the cell sorter can sort into at the same time, gates have to be 
sampled successively. This may waste a huge number of labeled cells, because cells that hit unselected gates will be discarded. The 
experimenter can adopt an alternative, convoluted sorting strategy instead that permits sorting into all gates simultaneously. In this 
approach, cells from different gates are sorted into the same sample tubes. Successive sorts that combine different sets of gates can be 
carried out, which enables back-calculation of the number of cells in each gate for each clone in the subsequent analysis (see Note 17). 
For N gates, prepare N unique combinations of gates. A gate must not be paired with any other gate more than once in these 
combinations. Sort orthogonal sets of combinations successively. For example, if 12 gates are chosen and the sorter can only sort into 
four sample tubes at the same time, the following set of combinations would be appropriate: {1,2,3}, {4,5,6}, {7,8,9}, {10,11,12}, 
{1,4,7}, {2,5,10}, {3,8,11}, {6,9,12}, {1,5,8}, {2,4,11}, {3,9,10}, {6,7,12}. Note that any pair of two gate indices appears together at 
most once. This set of combinations could be processed in three successive sorts collecting four pools of cells (each pool derived from 
three gates, all pools sorted into individual sample tubes) at a time: first {1,2,3}, {4,5,6}, {7,8,9}, {10,11,12}, then {1,4,7}, {2,5,10}, 
{3,8,11}, {6,9,12}, then {1,5,8}, {2,4,11}, {3,9,10}, {6,7,12}.
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3.4.2 DNA Amplification and adapter attachment—Most of this section is based on 
the excellent preparation protocol in [21].
1. For each sorted sample, separately, amplify DNA sequences encoding the 
peptide ligands out of plasmids by PCR. The 5' end of the forward primer 
needs to contain a binding site for the MmeI restriction enzyme: 5' 
GGGACCACCACCTCCGAC 3' (see Note 11). The 5' end of the reverse 
primer has to consist of a part of the Illumina adapter sequence: 5' 
CGGTCTCGGCATTCCTGC 3' (see Notes 12 & 13).
2. Purify PCR products with the Qiagen PCR-purification kit. Elute in 30 µl 
sterile water.
3. Digest the PCR product with the MmeI restriction enzyme. Incubate the 
digestion mixture for 1 h at 37 °C, then heat inactivate for 20 minutes at 80 °C 
(see Note 14).
digestion reagents
PCR product 12.5 µl
1mM SAM 2.5 µl
NEB Cut Smart Buffer 5 µl
MmeI 5 µl per 8.6 pmol PCR product
sterile water fill up to 50 µl
4. Prepare double-stranded adapters by annealing single-stranded oligos. The 
forward strand should contain the standard Illumina read binding site [22], a 
unique barcode for multiplexing (Note 15) and a 3' TC, giving : 5' 
ACACTCTTTCCCTACACGACGCTCTTCCGATCTbarcodeTC 3'. The 
reverse complement strand should be 5' phosphorylated and lack the 5' GA 3' 
that would be complementary to the TC of the forward strand.
5. Ligate each digestion product with an adapter containing a unique barcode. 
Ligate for 30 minutes at 20 °C, then heat inactivate for 10 minutes at 65 °C.
6. Run the products of the ligation reaction on a gel. Gel purify the bands of 
correct size with the Qiaquick gel purification kit. Elute in 30 µl sterile water.
11MmeI recognizes the sequence 5' TCCRAC 3'. Additional nucleotides 5' of the binding site can improve binding (e.g. 5' 
GGGACCACCACC 3' in point 1, section 3.4.2). MmeI cuts 20 nucleotides 3' of its binding sequence.
12Use high fidelity polymerase and as few PCR cycles as possible in order to reduce errors and amplification bias. 25 cycles generally 
suffice with the Phusion Polymerase standard protocol.
13High salt content from the DNA extraction step may prove inhibitory to sufficient amplification. 5 µl DNA extract in a 100 µl 
reaction mixture generally provides enough dilution to obtain satisfactory results.
14Excess MmeI may block digestion. MmeI activity also gets curbed by high amounts of salt. Excess salt may enter the reaction 
mixture via the PCR product from the PCR purification step. In addition, MmeI has a very low turnover and stoichiometric amounts of 
MmeI are required for sufficient digestion. Experimenters need to take special care to use the exact amounts of PCR product and 
MmeI indicated in the Materials section.
15Diverse barcodes at the beginning of a deep sequencing read are required to ensure proper calibration of the base calling algorithm. 
Barcodes need to be at least 5 nucleotides long, and deep sequencing runs should be multiplexed with at least 20 different barcodes. 
Barcode sequences should vary such that all bases appear in each position with roughly the same frequency.
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7. PCR-amplify the ligation product. Primers should contain overhangs that 
complete the Illumina adapter sequences.
Forward: 5' 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCT 
3'
Reverse: 5' 
CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCATCTT 
3'
15 PCR cycles should be sufficient using Phusion polymerase.
8. Purify PCR products with the Qiagen PCR-purification kit. Elute in 30 µl 
sterile water.
9. Combine samples and perform a multiplexed deep sequencing run on an 
Illumina sequencer with the standard forward Illumina read primer: 5' 
ACACTCTTTCCCTACACGACGCTCTTCCGATCT 3'. If a reverse read is 
also to be carried out use a custom primer (see Note 16).
3.5 Computational analysis
1. Filter the Illumina data by only considering sequences with a high Phred score 
for the mutated positions and a low number of read errors in unmutated 
positions (see Note 17). If a reverse read has been performed that overlaps the 
forward read, compare complementary mutant codons and choose the version 
with the higher Phred score.
2. Assign each Illumina read to its sorted pool/gate by barcode identification.
3. Count the copies of each unique sequence across all pools. Discard sequences 
with low copy numbers when summing up counts from all gates. Calculate the 
number of sorted cells that each unique sequence likely originated from. 
Dividing the number of cells that were sorted into a pool by the number of 
sequence reads for this sample provides a rough estimate of the cells per read. 
As a rule of thumb, require at least 100 sorted cells for each observed 
sequence.
4. If a convoluted sort strategy was used, see Note 18. Otherwise, calculate the 
distribution over the gates for each unique sequence.
16Sequencing a library can be a difficult task for Illumina sequencers, because current base calling algorithms expect significant 
sequence variety for all positions of a sample whereas library samples generally contain regions of constant sequence. Spiking PhiX 
genome into the sample may help alleviate problems, as may running a reference lane with PhiX genome on the same flow cell.
17MmeI sometimes cuts 19 or 21 bases 3' of its binding site. Furthermore, the TC 3' of the barcode may be missing in some reads. A 
small fraction of undigested by ligated sample may also be observed.
18Analyze deep sequencing from convoluted sorts (see Note 9) in the following way: For each sequence j calculate its frequency in 
each pool x as:
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Here, fxj is the normalized frequency of sequence j in gate x, nxj is the number 
of reads of sequence j in deep sequencing data set x (which corresponds to gate 
x), zx is the number of cells that hit gate x when measuring the distribution of 
cells across all gates.
5. Calculate all possible pairwise probabilities that a peptide A is a stronger 
binder than a peptide B and vice versa:
Note that gate indices x and y are assigned from lowest to highest affinity 
gates, i.e. in the equation the sum over y runs over all gates that are smaller in 
affinity than gate x. Assign these probabilities as weights to the edges of a 
directed graph. The vertices of the graph represent peptides and the directed 
edge running from vertex B to vertex A indicates the assumption that peptide A 
is a stronger binder than peptide B(Figure 5 A).
6. Find the maximum linear subgraph by first applying the method described in 
[23]. To do this, randomly chose a peptide/vertex A. For each other peptide/
vertex B, compare the edge weights of the two edges that connect it to A. If 
p(A>B) > p(B>A), ), then B is considered a worse binder than A, if p(B>A) > 
p(A>B) then B is considered a better binder than A. Group all peptides 
according to whether they are better vs. worse binders than A. Then, within 
each group, repeat the procedure of randomly choosing one peptide and 
evaluating all others with respect to it, continuing to subdivide the groups until 
an ordering from best to worst binder has been constructed. Determine the 
likelihood score for this ordering by summing up the logarithms of the edge 
with nxj being the number of reads for sequence j in pool x. Then calculate the corrected number of cells in pool x that contained 
sequence j as
where zy is the number of cells that hit gate y considering the distribution of cells across all gates, and the index y runs over all those 
gates that are part of pool x. Solve a linear equation system of the form
for the elements of vector Qj. The xth entry of the vector Mj is mxi. The entry dxyj in the xth row and yth column of matrix Dj is 1 if 
gate y is part of pool x and zero otherwise. The entry qyj in vector Qj is the time corrected number of cells in gate y. Normalize vector 
Qj to obtain the frequencies that are required for point 5.
Reich et al. Page 8
Methods Mol Biol. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
weights for all directed edges that agree with the ordering (Figure 5 B). Repeat 
the procedure of constructing an ordering several times and retain the one with 
the best score. Further refine this ordering by inserting each individual peptide 
into all possible positions and keeping the new position if a better score is 
obtained. Run the routine several times, alternately starting with the best and 
the worst binding peptide. Finally, run a Monte-Carlo search in which moves 
correspond to exchanging the positions of two peptides in the ordering. The 
final result represents an affinity ranking of all peptides.
Acknowledgments
The authors thank Vincent Xue for preparing figure 1. The authors express their gratitude to the Swanson 
Biotechnology Center Flow Cytometry Facility and the MIT BioMicro Center for technical support.
This protocol was developed with support from NIGMS under award GM096466. It was also funded by grant no. 
RE 3111/1-1 of the German Merit Foundation to LR.
Figures 2A, 3 and 4 were reprinted from Publication “SORTCERY – a high-throughput method to affinity rank 
peptide ligands”; Reich L, Dutta S, Keating AE; JMB; DOI: 10.1016/j.jmb.2014.09.025 with permission from 
Elsevier.
References
1. Hietpas RT, Jensen JD, Bolon DNA. Experimental illumination of a fitness landscape. Proc Natl 
Acad Sci USA. 2011; 108:78967901.
2. DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, et al. High-throughput 
sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nat Biotechnol. 
2013; 31:166–169. [PubMed: 23334449] 
3. Ernst A, Gfeller D, Kan Z, Seshagiri S, Kim PM, Baderet GD, et al. Coevolution of PDZ domain-
ligand interactions analyzed by high-throughput phage display and deep sequencing. Mol Biosyst. 
2010; 6:1782–1790. [PubMed: 20714644] 
4. DeBartolo J, Dutta S, Reich L, Keating AE. Predictive Bcl-2 Family Binding Models Rooted in 
Experiment or Structure. J Mol Biol. 2012; 422:124–144. [PubMed: 22617328] 
5. Jolma A, Kivioja T, Toivonen J, Cheng L, Wei G, Enge M. Multiplexed massively parallel SELEX 
for characterization of human transcription factor binding specificities. Genome Research. 2010; 
861:861–873. [PubMed: 20378718] 
6. Reynolds KA, McLaughlin RN, Ranganathan R. Hot Spots for Allosteric Regulation on Protein 
Surfaces. Cell. 2011; 147:1564–1575. [PubMed: 22196731] 
7. McLaughlin RN Jr, Poelwijk FJ, Raman A, Gosal WS, Ranganathan R. The spatial architecture of 
protein function and adaptation. Nature. 2012; 491:138–142. [PubMed: 23041932] 
8. Fowler DM, Araya CL, Fleishman SJ, Kellogg EH, Stephany JJ, Baker D, et al. High-resolution 
mapping of protein sequence-function relationships. Nat Methods. 2010; 7:741–746. [PubMed: 
20711194] 
9. Whitehead TA, Chevalier A, Song Y, Dreyfus C, Fleishman SJ, DeMattos C, et al. Optimization of 
affinity, specificity and function of designed influenza inhibitors using deep sequencing. Nat 
Biotechnol. 2012; 30:543–548. [PubMed: 22634563] 
10. Zhu J, Larman HB, Gao G, Somwar R, Zijuan Zhang Z, Lasersonet U, et al. Protein interaction 
discovery using parallel analysis of translated ORFs (PLATO). Nat Biotechnol. 2013; 31:331–333. 
[PubMed: 23503679] 
11. Tinberg CE, Khare SD, Dou J, Doyle L, Nelson JW, Schena A, et al. Computational design of 
ligand-binding proteins with high affinity and selectivity. Nature. 2013; 501:212–218. [PubMed: 
24005320] 
Reich et al. Page 9
Methods Mol Biol. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
12. Araya CL, Fowler DM, Chen W, Muniez I, Kelly JW, Fields S. A fundamental protein property, 
thermodynamic stability, revealed solely from large-scale measurements of protein function. Proc 
Natl Acad Sci USA. 2012; 109:16858–16863. [PubMed: 23035249] 
13. Starita LM, Pruneda JN, Russell SL, Fowler DM, Kim HJ, Hiatt JB, et al. Activity-enhancing 
mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesis. Proc Natl Acad Sci 
USA. 2013:E1263–E1272. [PubMed: 23509263] 
14. Melamed D, Young DL, Gamble CE, Miller CR, Fields S. Deep mutational scanning of an RRM 
domain of the Saccharomyces cerevisiae poly(A)-binding protein. RNA. 2013; 19:1537–1551. 
[PubMed: 24064791] 
15. Kinney JB, Murugana A, Callan CG Jr, Cox EC. Using deep sequencing to characterize the 
biophysical mechanism of a transcriptional regulatory sequence. Proc Natl Acad Sci USA. 2010; 
107:9158–9163. [PubMed: 20439748] 
16. Sharon E, Kalma Y, Sharp A, Raveh-Sadka T, Levo M, Zeevi D, et al. Inferring gene regulatory 
logic from high-throughput measurements of thousands of systematically designed promoters. Nat 
Biotechnol. 2012; 30:521–530. [PubMed: 22609971] 
17. Chao G, Lau WL, Hackel BJ, Sazinsky SL, Lippow SM, Wittrup KD. Isolating and engineering 
human antibodies using yeast surface display. Nat Prot. 2006; 1:755–768.
18. Liang JC, Chang AL, Kennedy AB, Smolke CD. A high-throughput, quantitative cell-based screen 
for efficient tailoring of RNA device activity. Nucleic Acids Res. 2012; 40:138–142.
19. Dutta S, Koide A, Koide S. High-throughput Analysis of the Protein SequenceStability Landscape 
using a Quantitative Yeast Surface Two-hybrid System and Fragment Reconstitution. J Mol Biol. 
2008; 382:721–733. [PubMed: 18674545] 
20. Reich L, Dutta S, Keating AE. SORTCERY - a high-throughput method to affinity rank peptide 
ligands. J Mol Biol. 2015; 427:2135–2150. [PubMed: 25311858] 
21. Hietpas R, Roscoe B, Jiang L, Bolon DNA. Fitness analyses of all possible point mutations for 
regions of genes in yeast. Nat Protoc. 2012; 7:1382–1396. [PubMed: 22722372] 
22. Illumina. [Accessed 13 Feb 2016] Illumina Adapter Sequences, Document # 1000000002694 v00. 
2015. Available on the Illumina web site. http://support.illumina.com/downloads/illumina-
customer-sequence-letter.html
23. Ailon N, Charikar M, Newman A. Aggregating Inconsistent Information: Ranking and Clustering. 
J ACM. 2008; 55 article 23. 
24. Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat 
Biotechnol. 1997; 15:553–557. [PubMed: 9181578] 
Reich et al. Page 10
Methods Mol Biol. Author manuscript; available in PMC 2017 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
A) SORTCERY combines experimental and computational protocols to rank peptide ligands 
according to their affinity for a target. Yeast-displayed peptides are sorted into pools that 
include ligands of similar affinity using FACS. Deep sequencing information is generated for 
each sample and the distribution of each sequence over the FACS gates is determined. 
Pairwise comparison of distributions permits the calculation of the probability that one 
peptide binds more strongly than another for each pair of peptides. A global rank order of 
affinities is computed from the probabilities. B) SORTCERY's yeast-display and gate-setting 
scheme. Peptide expression and target binding are detected via tags that are recognized by 
pairs of primary and fluorescently labeled secondary antibodies. Two-color cell sorting is 
based on these two signals. Gates are set to optimally separate binders of different affinities 
and to exclude non-binders and non-expressing cells.
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Figure 2. 
A) Individually measured dissociation constants vs. SORTCERY ranking indices for 19 
sequences from a ranking of ~1000 sequences. Clones have been reindexed from 1 to 19. 
Error bars for rank indices are 95% bootstrap confidence intervals: error bars for dissociation 
constants indicate standard deviations for four individual measurements. B) Ranking indices 
for the same 19 clones as determined by convoluted SORTCERY (see Note 9).
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Figure 3. 
Gate-setting for an affinity sort with 12 gates. The red, diagonal lines subdivide the axis of 
affinity into different intervals and thus insure that each gate corresponds to a unique range 
of dissociation constants. The green, lower- left borders exclude non-binding cells from 
higher-affinity gates and exclude non-expressing cells from all gates. The depicted FACS 
profile of a non-binder illustrates this. The blue, upper-right borders exclude cells with the 
maximum possible expression or binding signal, because affinities cannot be accurately 
estimated from such signals.
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Figure 4. 
FACS profile for a BH3 peptide ligand binding to Bcl-xL. The red line indicates the 
orientation of the first principle component for the expressing cells.
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Figure 5. 
A) A directed graph representing four peptide ligands and assumptions about their relative 
binding strengths. Each edge is weighted by the probability that the ligand at its base is a 
weaker binder than the ligand at its head. B) A linear subgraph of A). Note that no 
conflicting assumptions about binding strengths exist.
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